Biolase (BIOL) Reports Q3 Loss of $0.07/Share

Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.07), versus ($0.09) reported last year. Revenue for the quarter came in at $13.2 million, versus $11.2 million reported last year.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c